Inhibrx has initiated a phase 2 clinical trial to treat unresectable or metastatic conventional chondrosarcoma. The poster was presented at the Connective Tissue Oncology Society (CTOS) in Vancouver, Canada from November 16-19. The results of the…

Inhibrx is recruiting for Chondrosarcoma patients to participate in their Phase 2 study of the medication. Presently there are 130 openings for the Phase 2 trial. Summary is listed below, for more…

SAN DIEGO, Oct. 20, 2022 /PRNewswire/ — Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, today announced it will be presenting at multiple upcoming…

Here are pictures from our event: Steppin’ for A Cause held on October 15, at Allen Pond in Bowie, Maryland. We had 50 people participate in our 5k Walk / Run and raised $3,200 ($500 more than last year). Thank you to everyone for your…

Please enjoy the pictures of Ricky Ashman’s sky dive in Salisbury, United Kingdom. He raised over 1300 pounds for the Chondrosarcoma Foundation to honor his mother Harriet Stone who is a Chondrosarcoma Warrior. He jumped from 15,000 feet, flying at…

Check out this amazing video of Ricky Ashman’s sky dive in Salisbury, United Kingdom. He raised over 1300 Sterling for the Chondrosarcoma Foundation to honor his mother Harriet Stone who is a Chondrosarcoma Warrior. He jumped from 15,000 feet,…

One weeks from today!!! The Chondrosarcoma Foundation will host its Second Annual 5k Walk / Run to support research for Chondrosarcoma on October 15, 2022. https://www.eventbrite.com/e/406505638307 We are honoring the legacy of Shayna Elise…